Source: US News & World Report
“Results from a very small study suggest that a combination of the diabetes drug Ozempic and an innovative new intestinal procedure could help erase the need for insulin in folks with type 2 diabetes. The new trial hasn’t yet been published in a peer-reviewed journal and it included only 14 patients. The findings were presented Sunday at the United European Gastroenterology annual meeting in Vienna. The intestinal procedure used in the new trial was pioneered by researchers at the Mayo Clinic in the United States. It’s called Endoscopic re-cellularization via electroporation therapy (ReCET).” (10/14/24)